These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30358932)

  • 21. Defining a Cohort that May Not Require Repeat Prostate Biopsy Based on PCA3 Score and Magnetic Resonance Imaging: The Dual Negative Effect.
    Perlis N; Al-Kasab T; Ahmad A; Goldberg E; Fadak K; Sayyid R; Finelli A; Kulkarni G; Hamilton R; Zlotta A; Ghai S; Fleshner N
    J Urol; 2018 May; 199(5):1182-1187. PubMed ID: 29175542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate Biopsy in Active Surveillance Protocols: Immediate Re-biopsy and Timing of Subsequent Biopsies.
    Wang JH; Downs TM; Jason Abel E; Richards KA; Jarrard DF
    Curr Urol Rep; 2017 Jul; 18(7):48. PubMed ID: 28589399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy.
    Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Pennisi M; Morgia G
    Scand J Urol; 2017 Aug; 51(4):260-263. PubMed ID: 28513296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of mpMRI in active surveillance for localized prostate cancer.
    Scarpato KR; Barocas DA
    Urol Oncol; 2016 Jul; 34(7):320-5. PubMed ID: 27036218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Magnetic resonance imaging facilitate appropriate treatment selection of prostate cancer patients].
    Boesen L; Thomsen HS
    Ugeskr Laeger; 2013 Jun; 175(23):1634-7. PubMed ID: 23731990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endorectal multiparametric MRI of the prostate: incremental effect of perfusion imaging on biopsy target identification.
    Romero G; Foster BR; Pettersson DR; Fung AW; Guimaraes AR; Coakley FV
    Clin Imaging; 2016; 40(3):553-7. PubMed ID: 27133703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
    Sheridan AD; Nath SK; Syed JS; Aneja S; Sprenkle PC; Weinreb JC; Spektor M
    AJR Am J Roentgenol; 2018 Feb; 210(2):347-357. PubMed ID: 29112469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
    Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
    Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
    Durmus T; Baur A; Hamm B
    Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.
    Borkowetz A; Renner T; Platzek I; Toma M; Herout R; Baunacke M; Groeben C; Huber J; Laniado M; Baretton GB; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2018; 100(2):155-163. PubMed ID: 29339663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
    Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
    Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies.
    Covin B; Roumiguié M; Quintyn-Ranty ML; Graff P; Khalifa J; Aziza R; Ploussard G; Portalez D; Malavaud B
    World J Urol; 2019 Feb; 37(2):269-275. PubMed ID: 30145777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer.
    Fütterer JJ
    Korean J Radiol; 2017; 18(4):597-606. PubMed ID: 28670154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MR imaging of the Prostate: Pitfalls in Interpretation.
    Thomas S; Oto A
    Radiol Clin North Am; 2018 Mar; 56(2):277-287. PubMed ID: 29420982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.
    Wysock JS; Mendhiratta N; Zattoni F; Meng X; Bjurlin M; Huang WC; Lepor H; Rosenkrantz AB; Taneja SS
    BJU Int; 2016 Oct; 118(4):515-20. PubMed ID: 26800439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.
    Ma TM; Tosoian JJ; Schaeffer EM; Landis P; Wolf S; Macura KJ; Epstein JI; Mamawala M; Carter HB
    Eur Urol; 2017 Feb; 71(2):174-180. PubMed ID: 27236496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using multiparametric MRI to 'personalize' biopsy for men.
    Mendhiratta N; Meng X; Taneja SS
    Curr Opin Urol; 2015 Nov; 25(6):498-503. PubMed ID: 26414608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will all patients with suspicion of prostate cancer undergo multiparametric MRI before biopsy in the future?
    Rouvière O
    Diagn Interv Imaging; 2016 Apr; 97(4):389-91. PubMed ID: 27020474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.